All Stories

Alcon gains upper hand in Aurion power struggle via majority stake, removing CEO

Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage biotech and replacing its CEO.

Mar 27, 2025 - 23:12
 0
Alcon gains upper hand in Aurion power struggle via majority stake, removing CEO
Eye care giant Alcon appears to have gained the upper hand in the ongoing power struggle with Aurion Biotech by securing a majority stake in the clinical-stage biotech and replacing its CEO.
Read More

Tags:

Previous Article

Equillium misses primary endpoint, plus 2 key secondaries, but still plans appro...

Next Article

Nkarta lays off 3rd of staff, including CFO, to fund autoimmune CAR NK program

Related Posts

Options shrink for Supernus depression drug candidate after key trial failure

Options shrink for Supernus depression drug candidate a...

Feb 19, 2025  0

Journey of Voyager's ALS gene therapy to clinic hindered by need to find alternative payload

Journey of Voyager's ALS gene therapy to clinic hindere...

Feb 12, 2025  0

Chutes & Ladders—Yet another exec departs CRISPR Tx

Chutes & Ladders—Yet another exec departs CRISPR Tx

Mar 28, 2025  0